PHARMA MAR, S.A. «12345...» Página 4 de 18 desde 01/07/1988 hasta 26/09/2024 26/04/2019 12:42 PHARMA MAR, S.A. Strategic agreements with third parties Pharma Mar and Luye Pharma Group Ltd. has signed a license, development and commercialization agreement for lurbinectedina in China, Macao and Hong-Kong. Número de registro: 277486 04/04/2019 17:44 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 01/01/2019 and 31/03/2019 Número de registro: 276768 01/04/2019 08:18 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Press release regarding oral presentation at the next annual meeting of the American Society of Clinical Oncology Número de registro: 276625 Relacionado con 278282 del 16/05/2019 (07:37) Rectificado por 276622 del 01/04/2019 (07:56) 01/04/2019 07:56 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Press release regarding oral presentation at the next annual meeting of the American Society of Clinical Oncology Número de registro: 276622 Rectificado por 276625 del 01/04/2019 (08:18) 25/03/2019 08:05 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Achievement of primary endpoint in Phase II trial for Zepsyre Número de registro: 276396 28/02/2019 20:00 PHARMA MAR, S.A. Board of directors remuneration annual statement La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2018 Número de registro: 275529 28/02/2019 19:56 PHARMA MAR, S.A. Corporate governance annual report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2018 Número de registro: 275527 28/02/2019 19:35 PHARMA MAR, S.A. Announcements of public presentations and meetings The Company announces that it plans to hold a teleconference to comment on the financial results for 2018. Número de registro: 275521 28/02/2019 19:26 PHARMA MAR, S.A. Information on P&L The Company sends release regarging year 2018 results. Número de registro: 275519 28/02/2019 18:52 PHARMA MAR, S.A. Interim financial information La sociedad remite información sobre los resultados del segundo semestre de 2018 Número de registro: 275514 Página 4 de 18 «12345...»